FDA Approves Meloxicam Injection For Moderate-to-Severe Pain in Adults
Pharmacy Times
JUNE 10, 2025
1 "[Meloxicam injection] demonstrates our commitment to improving patient care by providing an alternate dosage form for pain management," Ron Scarboro, chief executive officer at Azurity Pharmaceuticals, said in a press release. Seminars in Arthritis and Rheumatism. PR Newswire. June 10, 2025. Accessed June 10, 2025.
Let's personalize your content